OVARIAN UNDIFFERENTIATED CARCINOMA
Clinical trials for OVARIAN UNDIFFERENTIATED CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN UNDIFFERENTIATED CARCINOMA trials appear
Sign up with your email to follow new studies for OVARIAN UNDIFFERENTIATED CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo could replace chemo for recurrent ovarian cancer
Disease control OngoingThis study tests whether the drugs olaparib and cediranib, alone or together, work better than standard chemotherapy for women with ovarian, fallopian tube, or peritoneal cancer that has returned after initial treatment. About 579 women with platinum-sensitive cancer are particip…
Matched conditions: OVARIAN UNDIFFERENTIATED CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 29, 2026 01:35 UTC
-
Measles virus hijacks stem cells to attack returning ovarian cancer
Disease control OngoingThis early-stage trial tests a new way to treat ovarian cancer that has come back after standard chemotherapy. Doctors take stem cells from the patient's own fat tissue, infect them with a specially modified measles virus, and inject them into the belly. The stem cells act like d…
Matched conditions: OVARIAN UNDIFFERENTIATED CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC